Company Filing History:
Years Active: 1989
Title: The Innovations of Thomas Maciag
Introduction
Thomas Maciag is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of recombinant DNA technology. His work has implications for both diagnostic applications and potential treatments for damaged blood vessels.
Latest Patents
Maciag holds a patent for a recombinant DNA vector encoding human endothelial cell growth factor. This invention utilizes recombinant DNA technology to create cloning vehicles that encode the endothelial cell growth factor (ECGF) protein. The procedures outlined in his patent allow for the recovery of ECGF protein that is essentially free of other human-origin proteins. This product is particularly useful in various diagnostic applications and holds promise for treating damaged blood vessels and other endothelial cell-line structures. He has 1 patent to his name.
Career Highlights
Throughout his career, Maciag has worked with prominent organizations, including Rorer Biotechnology Inc. and the American National Red Cross. His experience in these institutions has allowed him to contribute to advancements in biotechnology and healthcare.
Collaborations
Maciag has collaborated with several professionals in his field, including Michael Jaye and Wilson Burgess. These collaborations have further enriched his work and expanded the impact of his inventions.
Conclusion
Thomas Maciag's contributions to biotechnology, particularly through his patent on endothelial cell growth factor, highlight his innovative spirit and dedication to improving medical treatments. His work continues to influence the field and offers hope for future advancements in healthcare.